Medical research

Opt-out universal hep C screening in emergency dept is useful

Emergency department opt-out universal hepatitis C virus (HCV) screening can identify a large number of unrecognized HCV infections, including among those born after 1965, according to research published in the May 15 issue ...

HIV & AIDS

Bundled rapid HIV/Hep C testing may improve infection awareness

(HealthDay)—For people with substance use disorders, combining HIV and hepatitis C virus (HCV) testing and providing immediate test results may increase the number of people who are aware of their infection status, according ...

Diseases, Conditions, Syndromes

Improvements needed for hepatitis C testing in youth

A new study led by Boston Medical Center uncovered a need to improve testing rates for Hepatitis C Virus (HCV) in young people, specifically those with documented substance use history. In the national data sample, under ...

Diseases, Conditions, Syndromes

Mavyret approved as 8-week treatment for hep C, compensated cirrhosis

(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through ...

Diseases, Conditions, Syndromes

FDA approves mavyret for children, adolescents with hep C

(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday.

Diseases, Conditions, Syndromes

Direct-acting antivirals effective for hepatitis C in seniors

(HealthDay)—For older patients with hepatitis C virus (HCV), direct-acting antiviral (DAA) therapy is effective, according to a study published online May 25 in the Journal of the American Geriatrics Society.

Diabetes

Diabetes ups risk of HCC, death in patients with hepatitis C

(HealthDay)—For hepatitis C virus (HCV)-infected patients, diabetes mellitus (DM) is associated with increased risk of hepatocellular carcinoma (HCC) development and all-cause mortality, according to a study published online ...

Oncology & Cancer

Having HIV and chronic HBV/HCV coinfection may increase cancer risk

In HIV-infected patients receiving antiretroviral therapy (ART), chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is associated with an increased risk for non-Hodgkin's lymphoma. The findings are published ...

page 1 from 4